ACCESS CHINA Boston Registered Attendee list
Tentative attendee list as of April 25, 2023.
*In the order of registration. Please note that only the final confirmation letter serves as confirmation to attend the meeting.
Company Name | Chinese Name中文公司名 | Headquarter | Title | Company type |
Novo Nordisk | 诺和诺德 | Europe | Head of external innovation, Asia Pacific | Pharma |
Buchang Pharma | 步长制药 | China | BD Head | Pharma |
Ascendum Capital | Partner | Fund | ||
Hasten Biopharma | 海森生物医药 | China | Head of BD & Alliance | Pharma |
GenHouse Bio | 勤浩医药 | China | BD&Strategy Manager | Biotech |
Genhouse Bio | 勤浩医药 | China | CBO | Biotech |
Luoxin Pharmaceutical (Shanghai) | 罗欣药业(上海) | China | Senior Manager BD & Licensing | Pharma |
Tenacia Biotech | 元羿生物 | China | VP, Head of BD | Biotech |
BioRay Pharmaceuticals | 浙江博锐生物制药 | China | Head of Strategy & Business Development | Pharma |
Zhejiang jingxin pharmaceutical | 浙江京新药业 | China | BD Director | Pharma |
TaiRui Therapeutics | 上海鲐瑞医药科技 | China | Chairman and CEO | Biotech |
Walvax Biotechnology Co., Ltd. | 云南沃森生物 | China | Director of Business Development | Pharma,Biotech |
Eisai Innovation Inc | 卫材创新基金 | US | Managing Director | Pharma,Fund |
Abbisko Therapeutics | 和誉医药 | China | BD Head | Biotech |
Nanjing Chuangte | 南京创特 | China | CEO | Biotech |
Zelgen | 泽璟制药 | China | VP BD | Pharma |
Pfizer | 辉瑞 | US | Chiba search and evaluation lead | Pharma |
Global Law Firm | 环球律师事务所 | Marketing Manager | Other | |
Evive Biotech | 亿一生物 | China | CEO & CMO | Biotech |
D2M Biotherapeutics Inc | 丹码生物 | US | CEO | Biotech |
Fortress Biotech | US | Chief Financial Officer | Pharma,Biotech | |
AFT Pharmaceuticals Ltd | Rest of World | CEO | Pharma | |
Biosion | 博奥信生物 | China | CEO | Biotech |
Biosion | 博奥信生物 | China | COO | Biotech |
Biosion | 博奥信生物 | China | Associate Director BD | Biotech |
Panacea Venture | Panacea Venture | US | Partner | Fund |
Atriva Therapeutics | Europe | CEO | Biotech | |
Viva Biotech | Chief Innovation Officer, Head of Investment | Fund,Service provider | ||
Lumos Pharma | US | Chief Business Officer | Biotech | |
Virometix | Europe | Business Development | Biotech,Other: Strategic BD Advisor | |
Ark Biopharmaceuticals | 爱科百发 | China | VP, strategy and BD | Pharma,Biotech |
Neologics Bioscience | 苏州逻晟生物医药 | China | CEO | Biotech |
Aptamer Group | Europe | Management | Biotech | |
Huadong Medicine | 华东医药 | China | GM, BD & Investment | Pharma |
Everest Medicine | Senior Director Search & Evaluation | Biotech | ||
BeiGene | Executive Director | Biotech | ||
Dynamicure Biotech | US | CSO | Biotech | |
R-Pharm | Europe | Vice President, Global Partnering | Pharma | |
Vibrant Therapeutics | China | VP, Operation | Biotech | |
Grandpharma | BD senior manager | Pharma | ||
Pharos iBio | Asia | CBO | Biotech | |
AffaMed Therapeutics | China | Head of Alliance Management | Biotech | |
Sunmed Medtech | 嘉兴森迈医疗科技 | China | CMO | Medtech |
CEIBS | 中欧国际工商学院 | China | MBA | Other |
Kanova BioPharma | 鑫康合生物科技医药 | China | VP, BD | Biotech |
Caidya | 康缔亚 | US | BD VP | Service provider |
Nanodigmbio (Nanjing) Biotechnology Co., Ltd. | 纳昂达(南京)生物科技 | China | CEO | Biotech |
Protinhi Therapeutics | Europe | Business Developer | Pharma,Biotech | |
CStone Pharma | 基石药业 | China | AVP, BD and AM | Pharma |
Combimed | US | Chairman | Fund | |
Curadev | legal | Biotech | ||
Bilayer Therapeutics, Inc. | US | President & CEO | Biotech | |
Medicenna Therapeutics | Rest of World | Director, Corporate Development | Pharma | |
MICROVASCULAR THERAPEUTICS, INC | US | COO/CSO | Pharma,Biotech,Medtech | |
Neuren Pharmaceuticals | VP Corporate Development | Biotech | ||
Seno Medical Instruments, Inc. | US | President & CEO | Medtech | |
Kexing Biopharma | 科兴生物制药 | China | Vice General Manager | Pharma |
REDNVIA | Asia | Sr. BDM | Biotech | |
TAVOTEK | 拓创生物 | China | Management | |
Qure Bio | 启愈生物 | China | Management | |
PharmaSolux | 致谨生物 | China | Management | |
Immunophage Biotech | 艾美斐 | China | Chief Scientific Officer | Biotech |
iTabMed | 天劢源和 | China | Management | |
CellAct Pharma | Europe | Management | ||
WEX Pharma | Canada | Management | ||
Astrocyte Pharma | US | Management | ||
Regeneus | Sydney | Management | ||
Grand Pharma | 远大药业 | China | Management | |
ABM Therapeutics | 璧辰医药 | China | BD | |
ABM Therapeutics | 璧辰医药 | China | CEO | |
Antengene | 德琪医药 | China | Head of Global Business Development, Search & Evaluation | |
和其瑞医药(南京) | China | Head of Downstream | ||
Kaken Pharmaceutical | Japan | Senior Manager | ||
Yifan Pharmaceutical | 亿帆医药 | China | BD Director | |
Peg-Bio | Director, BD and Investment & Financing | |||
Lupin Pharmaceuticals | US | SVP and Executive Leader | ||
Gluetacs Therapeutics (Shanghai) | 标新生物 | China | Chief of Staff | |
I-Mab Biopharma | 天境生物 | China | Business Development Senior Manager | |
Merck | US | Executive Director,BD&L | ||
H.A.C.Pharma | Europe | Chairman & CEO, Founder | ||
Regor Therapeutics | 锐格医药 | China | Founder CEO | |
LIANSN Pharmaceuticals | 贵州联盛药业 | China | Director BD (R&D) | |
RedCloud Bio | 红云生物 | China | CEO, Board Director | |
LaNova Medicines | 礼新医药 | China | Manager, BD & Alliance Management | |
Teva Pharmaceuticals | Israel | General Manager, Greater China | ||
ImmuneOnco | 宜明昂科 | China | Senior Vice President Business Development | |
The Janssen Pharmaceutical Companies of Johnson & Johnson | Belgium | Senior Manager, Business Development | ||
Tenykin | 天汇资本 | China | Associate director, investment | |
Hope Medicine Inc | 和其瑞医药 | China | Head of Downstream |